Quantcast

Latest Ventricular assist device Stories

2014-09-12 08:24:55

From 1969 to September 5, 2014, 1,413 artificial hearts of 13 different designs have been implanted in heart failure patients. Here's an update on the state of this life-saving technology. TUCSON, Ariz., Sept. 12, 2014 /PRNewswire/ -- Cardiovascular disease, which includes heart failure, is the number one cause of death, killing more people worldwide than all cancers combined. http://photos.prnewswire.com/prnvar/20140911/145568 The need for donor hearts is growing as heart disease continues...

2014-09-09 16:26:44

PLEASANTON, Calif., Sept. 9, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun to enroll patients in the HeartMate III(TM) U.S. clinical trial. "We are excited to continue our recent pipeline progress with the start of the U.S. clinical trial for HeartMate III," said Gary F. Burbach, President and Chief Executive Officer....

2014-09-04 23:02:54

Memorial Regional Hospital is only one of two Ventricular Assisted Device programs now serving the South Florida community. Hollywood, Fl (PRWEB) September 04, 2014 Memorial Regional Hospital, a leading provider of adult cardiac services in Florida, recently earned The Joint Commission’s Gold Seal of Approval for its ventricular assist device (VAD) destination therapy program, offered through its Memorial Cardiac and Vascular Institute. Memorial Regional Hospital is the first hospital...

2014-09-03 08:32:39

O'Hara lost two siblings to genetic heart failure when he faced dying of the same condition. The SynCardia Heart implant bridged him to a matching donor heart transplant. Today, Pat is doing great. TUCSON, Ariz., Sept. 3, 2014 /PRNewswire/ -- With the help of the SynCardia temporary Total Artificial Heart, Patrick "Pat" O'Hara was bridged to a donor heart transplant and beat genetic heart failure that claimed the lives of two siblings and caused a third to have a heart attack....

2014-08-29 16:23:53

PLEASANTON, Calif., Aug. 29, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the 2014 Morgan Stanley Global Healthcare Conference on Wednesday, September 10. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the company, beginning at 12:55 p.m., Eastern Daylight Time (9:55 a.m., Pacific...

2014-08-06 16:29:25

PLEASANTON, Calif., Aug. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has entered into a $30 million Accelerated Share Repurchase (ASR) agreement. "This commitment to capital deployment reflects our ongoing conviction in the long term opportunities in our business," said Gary F. Burbach, President and Chief Executive Officer....

2014-08-06 16:29:23

PLEASANTON, Calif., Aug. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its CE Mark Clinical Trial for HeartMate PHP(TM) (Percutaneous Heart Pump) has commenced. "We are excited to begin the CE Mark Clinical Trial for HeartMate PHP and look forward to successful execution of this important clinical study," said Gary F. Burbach, President and...

2014-08-05 08:35:27

FRAMINGHAM, Mass., Aug. 5, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 34th Annual Growth Conference at 9:00 a.m. EDT on Thursday, August 14, 2014. The conference is being held August 13-14 at the InterContinental Boston. A...

2014-08-04 16:27:06

PLEASANTON, Calif., Aug. 4, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Canaccord Genuity 34(th) Annual Growth Conference on Wednesday, August 13. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 2:00 p.m., Eastern Daylight Time (11:00 a.m., Pacific...

2014-08-04 08:29:13

FRAMINGHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., as Chief Medical Officer of HeartWare, effective September 1, 2014. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.